Suchergebnisse

361 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: 神経膠細胞芽腫, Glioblastom, glioblastoma

• 2017, Al-Serori H, Kundi M, Ferk F, Mišík M, Nersesyan A, Murbach M, Lah TT, Knasmüller S
  Evaluation of the potential of mobile phone specific electromagnetic fields (UMTS) to produce micronuclei in human glioblastoma cell lines [med./bio.]
  Toxicol In Vitro 40: 264-271
• 2017, Su L, Wei X, Xu Z, Chen G
  RF-EMF exposure at 1800 MHz did not elicit DNA damage or abnormal cellular behaviors in different neurogenic cells [med./bio.]
  Bioelectromagnetics 38 (3): 175-185
• 2017, Akbarnejad Z, Eskandary H, Vergallo C, Nematollahi-Mahani SN, Dini L, Darvishzadeh-Mahani F, Ahmadi M
  [Details] Effects of extremely low-frequency pulsed electromagnetic fields (ELF-PEMFs) on glioblastoma cells (U87) [med./bio.]
  Electromagn Biol Med 36 (3): 238-247
• 2017, Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J
  [Details] A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma [Review]
  CNS Oncol 6 (1): 29-43
• 2016, Kim SC, Im W, Shim JY, Kim SK, Kim BJ
  Static magnetic field controls cell cycle in cultured human glioblastoma cells [med./bio.]
  Cytotechnology 68 (6): 2745-2751
• 2016, Saria MG, Kesari S
  Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy [Grundlagen]
  Clin J Oncol Nurs 20 (5): S9-S13
• 2016, Wenger C, Bomzon Z, Salvador R, Basser PJ, Miranda PC
  Simplified realistic human head model for simulating Tumor Treating Fields (TTFields) [tech./dosim.]
  2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA. IEEE: S. 5664-5667; ISBN 978-1-4577-0220-4
• 2016, Hershkovich HS, Bomzon Z, Wenger C, Urman N, Chaudhry A, Garcia-Carracedo D, Kirson ED, Weinberg U, Wassermann Y, Palti Y
  First steps to creating a platform for high throughput simulation of TTFields [tech./dosim.]
  2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA. IEEE: S. 2357-2360; ISBN 978-1-4577-0220-4
• 2016, Macedo M, Wenger C, Salvador R, Fernandes SR, Miranda PC
  Investigating an alternative ring design of transducer arrays for tumor treating fields (TTFields) [tech./dosim.]
  2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA. IEEE: S. 5168-5171; ISBN 978-1-4577-0220-4
• 2016, Tuszynski JA, Wenger C, Friesen DE, Preto J
  [Details] An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields [Review]
  Int J Environ Res Public Health 13 (11): E1128
• 2016, de Vocht F
  [Details] Inferring the 1985-2014 impact of mobile phone use on selected brain cancer subtypes using Bayesian structural time series and synthetic controls [epidem.]
  Environ Int 97: 100-107
• 2016, Pasi F, Fassina L, Mognaschi ME, Lupo G, Corbella F, Nano R, Capelli E
  Pulsed electromagnetic field with temozolomide can elicit an epigenetic pro-apoptotic effect on glioblastoma T98G cells [med./bio.]
  Anticancer Res 36 (11): 5821-5826
• 2016, Bardet SM, Carr L, Soueid M, Arnaud-Cormos D, Leveque P, O'Connor RP
  Multiphoton imaging reveals that nanosecond pulsed electric fields collapse tumor and normal vascular perfusion in human glioblastoma xenografts [med. Anw.]
  Sci Rep 6: 34443-
• 2016, Schwartz MA, Onuselogu L
  Rationale and background on tumor-treating fields for glioblastoma [Grundlagen]
  Clin J Oncol Nurs 20 (5): S20-S24
• 2016, Hottinger AF, Pacheco P, Stupp R
  Tumor treating fields: a novel treatment modality and its use in brain tumors [Grundlagen]
  Neuro Oncol 18 (10): 1338-1349
• 2016, Chamberlain MC
  Treatment for Patients With Newly Diagnosed Glioblastoma [Kommentar]
  JAMA 315 (21): 2348
• 2016, Stupp R, Toms SA, Kesari S
  Treatment for Patients With Newly Diagnosed Glioblastoma- Reply [Kommentar]
  JAMA 315 (21): 2348-2349
• 2016, Swanson KD, Lok E, Wong ET
  [Details] An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma [Review]
  Curr Neurol Neurosci Rep 16 (1): 8-
• 2016, Ansstas G, Tran DD
  Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series [Grundlagen]
  Case Rep Neurol 8 (1): 1-9
• 2016, Mohan S, Chawla S, Wang S, Verma G, Skolnik A, Brem S, Peters KB, Poptani H
  Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience [med./bio.]
  CNS Oncol 5 (3): 137-144
• 2016, Kim EH, Song HS, Yoo SH, Yoon M
  Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis [med./bio.]
  Oncotarget 7 (40): 65125-
• 2016, Kim EH, Kim YJ, Song HS, Jeong YK, Lee JY, Sung J, Yoo SH, Yoon M
  Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation [med./bio.]
  Oncotarget 7 (38): 62267-
• 2016, Chan AK, Birk HS, Winkler EA, Viner JA, Taylor JW, McDermott MW
  Stability of programmable shunt valve settings with simultaneous use of the Optune transducer array: a case report [Gerät/Impl.]
  Cureus 8 (7): e675-
• 2016, Orban C, Perez-Garcia E, Bajnok A, McBean G, Toldi G, Blanco-Fernandez A
  Real time kinetic flow cytometry measurements of cellular parameter changes evoked by nanosecond pulsed electric field [med./bio.]
  Cytometry A 89 (5): 472-479
• 2016, Huang YJ, Hoffmann G, Wheeler B, Schiapparelli P, Quinones-Hinojosa A, Searson P
  Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells [med./bio.]
  Sci Rep 6: 21583
• 2016, Wenger C, Salvador R, Basser PJ, Miranda PC
  Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts [tech./dosim.]
  Int J Radiat Oncol Biol Phys 94 (5): 1137-1143
• 2016, Kalakoti P, Murray RD, Pettersson-Segerlind J, Smeds H, Nanda A
  Cochlear implants in the etiopathogenesis of glioblastoma-an interesting observation or independent finding? [Grundlagen]
  Acta Neurochir 158 (5): 907-912
• 2015, Lok E, Hua V, Wong ET
  Computed modeling of alternating electric fields therapy for recurrent glioblastoma [tech./dosim.]
  Cancer Med 4 (11): 1697-1699
• 2015, Wenger C, Salvador R, Basser PJ, Miranda PC
  The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study [tech./dosim.]
  Phys Med Biol 60 (18): 7339-7357
• 2015, Sampson JH
  Alternating Electric Fields for the Treatment of Glioblastoma [Kommentar]
  JAMA 314 (23): 2511-2513
• 2015, Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z
  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial [med. Anw.]
  JAMA 314 (23): 2535-2543
• 2015, Taillibert S, Le Rhun E, Chamberlain MC
  [Details] Tumor treating fields: a new standard treatment for glioblastoma? [Review]
  Curr Opin Neurol 28 (6): 659-664
• 2015, Wong ET, Toms SA, Ahluwalia MS
  Technological advances in the treatment of cancer: combining modalities to optimize outcomes [Grundlagen]
  Clin Adv Hematol Oncol 13 (11) Suppl: 1-18
• 2015, Bomzon Z, Urman N, Wenger C, Giladi M, Weinberg U, Wasserman Y, Kirson ED, Miranda PC, Palti Y
  Modelling Tumor Treating Fields for the treatment of lung-based tumors [tech./dosim.]
  2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy. IEEE: S. 6888-6891; ISBN 978-1-4244-9271-8
• 2015, Wenger C, Giladi M, Bomzon Z, Salvador R, Basser PJ, Miranda PC
  Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase [tech./dosim.]
  2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy. IEEE: S. 6892-6895; ISBN 978-1-4244-9271-8
• 2015, Chaudhry A, Benson L, Varshaver M, Farber O, Weinberg U, Kirson E, Palti Y
  NovoTTF-100A system (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL system user study [med. Anw.]
  World J Surg Oncol 13: 316
• 2015, Winter L, Oezerdem C, Hoffmann W, van de Lindt T, Periquito J, Ji Y, Ghadjar P, Budach V, Wust P, Niendorf T
  Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz) [tech./dosim.]
  Radiat Oncol 10: 201
• 2015, Liu YX, Li GQ, Fu XP, Xue JH, Ji SP, Zhang ZW, Zhang Y, Li AM
  [Details] Exposure to 3G mobile phone signals does not affect the biological features of brain tumor cells [med./bio.]
  BMC Public Health 15: 764
• 2015, Wong ET, Lok E, Swanson KD
  [Details] An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas [Review]
  Curr Treat Options Oncol 16 (8): 40
• 2014, Lacouture ME, Davis ME, Elzinga G, Butowski N, Tran D, Villano JL, DiMeglio L, Davies AM, Wong ET
  Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma [med. Anw.]
  Semin Oncol 41: S1-S14
• 2014, Elzinga G, Wong ET
  Resolution of cystic enhancement to add-on tumor treating electric fields for recurrent glioblastoma after incomplete response to bevacizumab [med. Anw.]
  Case Rep Neurol 6 (1): 109-115
• 2014, Vymazal J, Wong ET
  Response patterns of recurrent glioblastomas treated with tumor-treating fields [med. Anw.]
  Semin Oncol 41: S14-S24
• 2014, Giladi M, Schneiderman RS, Porat Y, Munster M, Itzhaki A, Mordechovich D, Cahal S, Kirson ED, Weinberg U, Palti Y
  Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields [med./bio.]
  Pancreatology 14 (1): 54-63
• 2014, Miranda PC, Mekonnen A, Salvador R, Basser PJ
  Predicting the electric field distribution in the brain for the treatment of glioblastoma [tech./dosim.]
  Phys Med Biol 59 (15): 4137-4147
• 2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL
  Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. Anw.]
  Cancer Med 3 (3): 592-602
• 2014, Carlberg M, Hardell L
  [Details] Decreased Survival of Glioma Patients with Astrocytoma Grade IV (Glioblastoma Multiforme) Associated with Long-Term Use of Mobile and Cordless Phones [epidem.]
  Int J Environ Res Public Health 11 (10): 10790-10805
• 2014, Akhavan-Sigari R, Baf MM, Ariabod V, Rohde V, Rahighi S
  [Details] Connection between Cell Phone use, p53 Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses [med./bio.]
  Rare Tumors 6 (3): 5350
• 2014, Morgan LL, Kesari S, Davis DL
  [Details] Why children absorb more microwave radiation than adults: The consequences [Review]
  J Microsc Ultrastruct 2 (4): 197-204
• 2014, Turner SG, Gergel T, Wu H, Lacroix M, Toms SA
  The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM-100A system [med. Anw.]
  World J Surg Oncol 12: 162
• 2014, Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS
  [Details] The epidemiology of glioma in adults: a "state of the science" review [Review]
  Neuro Oncol 16 (7): 896-913